rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    RENB
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Lunai Bioworks reduces CEO base salary and amends employment agreement
      Nov 12Investing.comRENB
      Lunai Bioworks Seeks Nasdaq Trading Suspension Amid Probe

      Tipranks Press Release.

      Oct 10The Globe and MailRENB
      Lunai Bioworks Delays Annual SEC Filing Briefly

      Detailed price information for Lunai Bioworks Inc (LNAI-Q) from The Globe and Mail including charting and trades.

      Sep 30The Globe and MailRENB
      Lunai Bioworks secures exclusive Tanaist license for Parkinson’s
      Sep 22Investing.comRENB
      Lunai Bioworks (NASDAQ: LNAI) Expands Parkinson's Platform Through Exclusive Tanaist Agreement

      --Lunai Bioworks, Inc., a biology-first AI drug discovery company, today announced an exclusive worldwide license and collaboration agreement with Tanaist, Inc. that adds human cellular phenotyping to Lunai's growing Parkinson's disease discovery and validation platform. The collaboration is designed to connect patient subtypes identified by...

      Sep 22NasdaqRENB
      Lunai Bioworks (Nasdaq: LNAI) Demonstrates AI Chemical-Risk Screening for Generative AI

      Lunai Bioworks, Inc. (Nasdaq: LNAI) ("Lunai" or the "Company") today shared results from a technical case study conducted by its BioSymetrics subsidiary, supporting the development of structure-based screening tools for chemical outputs generated by large language models and other artificial intelligence systems. The study evaluates predicting acetylcholinesterase ("AChE") inhibition directly from molecular structure as a model-agnostic component of the Company's broader chemical-safety and bios

      Sep 16Yahoo FinanceRENB
      Lunai Bioworks (NASDAQ: LNAI) Issues Correction to Press Release Regarding Second Amended Complaint
      Sep 4MorningstarRENB
      Lunai Bioworks (Nasdaq: LNAI) Names Six Broker-Dealers in Expanded Naked Short Selling Suit

      Lunai Bioworks, Inc. (Nasdaq: LNAI) ("Lunai" or the "Company") today announced the filing of its Second Amended Complaint naming six registered broker-dealers and two broker-dealer principals as defendants for the first time, in the U.S. District Court for the District of Delaware (Civil Action No. 26-549-CFC).

      Aug 27Yahoo FinanceRENB

      This is the newest page. Registered accounts read further back.